Global Antibody Market Professional Survey Report 2016

June 2016 | 141 pages | ID: GF2C9DB6864EN
QYResearch

Abstracts

This report

Mainly covers the following product types

• IgG
• IgA
• Others

The segment applications including

• Tests
• Patients
• Others

Segment regions including (the separated region report can also be offered)

• Japan
• Australia
• China
• UK
• Germany
• France
• USA
• Others

The players list (Partly, Players you are interested in can also be added)

• Santa
• Cell Signaling Technology
• Abnova
• ABGENT
• R&D
• Millipore
• MBL
• Novus
• BD
• PeproTech
• Merck
• Biodesign
• Pierce
• Cayman
• Miltenyi Bioiec
• Assay Designs
• Dynal Biotech ASA.
• Roche
• BioLegend
• eBioscience
• SBA
• NeoMarkers
• BioVision
• KPL

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF ANTIBODY

1.1 Definition and Specifications of Antibody
  1.1.1 Definition of Antibody
  1.1.2 Specifications of Antibody
1.2 Classification of Antibody
  1.2.1 IgG
  1.2.2 IgA
  1.2.3 Others
1.3 Applications of Antibody
  1.3.1 Tests
  1.3.2 Patients
  1.3.3 Others
1.4 Industry Chain Structure of Antibody
1.5 Industry Overview and Major Regions Status of Antibody
  1.5.1 Industry Overview of Antibody
  1.5.2 Global Major Regions Status of Antibody
1.6 Industry Policy Analysis of Antibody
1.7 Industry News Analysis of Antibody

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTIBODY

2.1 Raw Material Suppliers and Price Analysis of Antibody
2.2 Equipment Suppliers and Price Analysis of Antibody
2.3 Labor Cost Analysis of Antibody
2.4 Other Costs Analysis of Antibody
2.5 Manufacturing Cost Structure Analysis of Antibody
2.6 Manufacturing Process Analysis of Antibody

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTIBODY

3.1 Capacity and Commercial Production Date of Global Antibody Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Antibody Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Antibody Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Antibody Major Manufacturers in 2015

4 GLOBAL ANTIBODY OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Antibody Capacity and Growth Rate Analysis
  4.2.2 2015 Antibody Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Antibody Sales and Growth Rate Analysis
  4.3.2 2015 Antibody Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Antibody Sales Price
  4.4.2 2015 Antibody Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Antibody Gross Margin
  4.5.2 2015 Antibody Gross Margin Analysis (Company Segment)

5 ANTIBODY REGIONAL MARKET ANALYSIS

5.1 Japan Antibody Market Analysis
  5.1.1 Japan Antibody Market Overview
  5.1.2 Japan 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 Japan 2011-2016E Antibody Sales Price Analysis
  5.1.4 Japan 2015 Antibody Market Share Analysis
5.2 Australia Antibody Market Analysis
  5.2.1 Australia Antibody Market Overview
  5.2.2 Australia 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Australia 2011-2016E Antibody Sales Price Analysis
  5.2.4 Australia 2015 Antibody Market Share Analysis
5.3 China Antibody Market Analysis
  5.3.1 China Antibody Market Overview
  5.3.2 China 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2011-2016E Antibody Sales Price Analysis
  5.3.4 China 2015 Antibody Market Share Analysis
5.4 UK Antibody Market Analysis
  5.4.1 UK Antibody Market Overview
  5.4.2 UK 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 UK 2011-2016E Antibody Sales Price Analysis
  5.4.4 UK 2015 Antibody Market Share Analysis
5.5 Germany Antibody Market Analysis
  5.5.1 Germany Antibody Market Overview
  5.5.2 Germany 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Germany 2011-2016E Antibody Sales Price Analysis
  5.5.4 Germany 2015 Antibody Market Share Analysis
5.6 France Antibody Market Analysis
  5.6.1 France Antibody Market Overview
  5.6.2 France 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 France 2011-2016E Antibody Sales Price Analysis
  5.6.4 France 2015 Antibody Market Share Analysis
5.7 USA Antibody Market Analysis
  5.7.1 USA Antibody Market Overview
  5.7.2 USA 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.7.3 USA 2011-2016E Antibody Sales Price Analysis
  5.7.4 USA 2015 Antibody Market Share Analysis
5.8 Others Antibody Market Analysis
  5.8.1 Others Antibody Market Overview
  5.8.2 Others 2011-2016E Antibody Local Supply, Import, Export, Local Consumption Analysis
  5.8.3 Others 2011-2016E Antibody Sales Price Analysis
  5.8.4 Others 2015 Antibody Market Share Analysis

6 GLOBAL 2011-2016E ANTIBODY SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Antibody Sales by Type
6.2 Different Types Antibody Product Interview Price Analysis
6.3 Different Types Antibody Product Driving Factors Analysis
  6.3.1 IgG Antibody Growth Driving Factor Analysis
  6.3.2 IgA Antibody Growth Driving Factor Analysis
  6.3.3 Others Antibody Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ANTIBODY SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Tests Antibody Growth Driving Factor Analysis
  7.3.2 Patients Antibody Growth Driving Factor Analysis
  7.3.3 Others Antibody Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTIBODY

8.1 Santa
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Santa 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Santa 2015 Antibody Business Region Distribution Analysis
8.2 Cell Signaling Technology
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Cell Signaling Technology 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Cell Signaling Technology 2015 Antibody Business Region Distribution Analysis
8.3 Abnova
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Abnova 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Abnova 2015 Antibody Business Region Distribution Analysis
8.4 ABGENT
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 ABGENT 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 ABGENT 2015 Antibody Business Region Distribution Analysis
8.5 R&D
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 R&D 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 R&D 2015 Antibody Business Region Distribution Analysis
8.6 Millipore
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Millipore 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Millipore 2015 Antibody Business Region Distribution Analysis
8.7 MBL
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 MBL 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 MBL 2015 Antibody Business Region Distribution Analysis
8.8 Novus
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Novus 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Novus 2015 Antibody Business Region Distribution Analysis
8.9 BD
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 BD 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 BD 2015 Antibody Business Region Distribution Analysis
8.10 PeproTech
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 PeproTech 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 PeproTech 2015 Antibody Business Region Distribution Analysis
8.11 Merck
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 Merck 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Merck 2015 Antibody Business Region Distribution Analysis
8.12 Biodesign
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Biodesign 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Biodesign 2015 Antibody Business Region Distribution Analysis
8.13 Pierce
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 Pierce 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Pierce 2015 Antibody Business Region Distribution Analysis
8.14 Cayman
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Cayman 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Cayman 2015 Antibody Business Region Distribution Analysis
8.15 Miltenyi Bioiec
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Miltenyi Bioiec 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Miltenyi Bioiec 2015 Antibody Business Region Distribution Analysis
8.16 Assay Designs
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 Assay Designs 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 Assay Designs 2015 Antibody Business Region Distribution Analysis
8.17 Dynal Biotech ASA.
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
  8.17.3 Dynal Biotech ASA. 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.17.4 Dynal Biotech ASA. 2015 Antibody Business Region Distribution Analysis
8.18 Roche
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
  8.18.3 Roche 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.18.4 Roche 2015 Antibody Business Region Distribution Analysis
8.19 BioLegend
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
  8.19.3 BioLegend 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.19.4 BioLegend 2015 Antibody Business Region Distribution Analysis
8.20 eBioscience
  8.20.1 Company Profile
  8.20.2 Product Picture and Specifications
  8.20.3 eBioscience 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.20.4 eBioscience 2015 Antibody Business Region Distribution Analysis
8.21 SBA
  8.21.1 Company Profile
  8.21.2 Product Picture and Specifications
  8.21.3 SBA 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.21.4 SBA 2015 Antibody Business Region Distribution Analysis
8.22 NeoMarkers
  8.22.1 Company Profile
  8.22.2 Product Picture and Specifications
  8.22.3 NeoMarkers 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.22.4 NeoMarkers 2015 Antibody Business Region Distribution Analysis
8.23 BioVision
  8.23.1 Company Profile
  8.23.2 Product Picture and Specifications
  8.23.3 BioVision 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.23.4 BioVision 2015 Antibody Business Region Distribution Analysis
8.24 KPL
  8.24.1 Company Profile
  8.24.2 Product Picture and Specifications
  8.24.3 KPL 2015 Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.24.4 KPL 2015 Antibody Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 Japan 2016-2021 Antibody Consumption Forecast
  9.2.2 Australia 2016-2021 Antibody Consumption Forecast
  9.2.3 China 2016-2021 Antibody Consumption Forecast
  9.2.4 UK 2016-2021 Antibody Consumption Forecast
  9.2.5 Germany 2016-2021 Antibody Consumption Forecast
  9.2.6 France 2016-2021 Antibody Consumption Forecast
  9.2.7 USA 2016-2021 Antibody Consumption Forecast
  9.2.8 Others 2016-2021 Antibody Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 ANTIBODY MARKETING MODEL ANALYSIS

10.1 Antibody Regional Marketing Model Analysis
10.2 Antibody International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Antibody by Regions
10.4 Antibody Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTIBODY

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ANTIBODY

12.1 New Project SWOT Analysis of Antibody
12.2 New Project Investment Feasibility Analysis of Antibody

13 CONCLUSION OF THE GLOBAL ANTIBODY MARKET PROFESSIONAL SURVEY REPORT 2016